The Center for Genetic Engineering and Biotechnology of Cuba reported this Saturday that it sent to Venezuela a batch of Abdala, the first vaccine against Covid-19 developed and produced in Latin America.
ALSO READ:
Cuba sends first batch of its Abdala anticovid vaccine to Vietnam
The scientific institution confirmed through a message on the social network Twitter the transfer to the Bolivarian nation of the antigen.
The text states that “doses of love and hope from our Abdala vaccine were sent (this Saturday) from Cuba and arrived safely to help the Venezuelan people in their fight against the current Covid-19 pandemic.
#Abdala came to the sister country of Venezuela !!!! Doses of love and hope of our Abdala vaccine were sent yesterday from Cuba and they arrived safely to help the Venezuelan people in their fight against the current COVID-19 pandemic. #CubaPorLaSalud pic.twitter.com/M1sqKyDQsd
– CIGBCuba (@CIGBCuba)
September 26, 2021
–
–
Abdala is given in three doses (zero, 14, and 28 days). It was designed by scientists from that center and achieved an efficiency of 92.28 percent. It also showed a 90 percent effectiveness in critically ill patients and against the Delta variant of Covid-19.
Likewise, the CIGB confirmed this Saturday that 30 million units of the serum were produced to guarantee the vaccination of the Cuban population over 19 years of age.
According to the press, this population group also includes pregnant women, nursing mothers, people with transplants, adolescents and young people in terminal grades of the national education system.
The doses of the Abdala vaccine for the Cuban people amount to 30 million !! Thanks to the experience of the Cuban biopharmaceutical industry, the talent of our scientists and the CIGB-AICA alliance, high technology institutions, which made this great challenge a reality. pic.twitter.com/rcNWBUgX7Z
– CIGBCuba (@CIGBCuba)
September 26, 2021
–
–
In another message on Twitter, the scientific institution expresses joy at having completed the coverage of the Cuban people and being able to help brother peoples, at a time when regions of the world are waiting for the first dose to vaccinate entire populations, as was widely denounced during the debates of the United Nations General Assembly.
When some regions in the world are still waiting for their first dose of vaccine, Cuba has managed to serve our highest priority: the Cuban people, and we are in a position to contribute doses of vaccines for other sister nations! !! #CubaEsRevolución pic.twitter.com/ryGn4AZUA8
– CIGBCuba (@CIGBCuba)
September 26, 2021
–
–
In addition, the CIGB announced on the delivery of 120,000 doses without thiomersal, which allowed to begin the immunization of people allergic to this component in Havana (capital) and in other territories of the island.
Thiomersal or thimerosal is present in many of the Cuban vaccines and was previously used for wound healing. In the case of vaccines that are multidose, this compound works as a preservative of the product.
Today Cuba has the vaccine #Abdala_ST for those allergic to thiomersal! CIGB and AICA delivered 120,000 doses to the ENCOMED company to guarantee immunization against SARS-CoV-2 infection in Cubans over 19 years of age who are allergic to this component. #CubaPorLaSalud pic.twitter.com/oMrGkKqTW4
– CIGBCuba (@CIGBCuba)
September 26, 2021
–
–
This Friday, the BioCubaFarma company announced the shipment to Vietnam of the first batch of Abdala, a fact that took place after the agreement signed between the CIGB and the Center for Research and Production of Vaccines and Medical Biological Products (Polyvac), belonging to the Asian nation. . The alliance foresees the supply and distribution of 5 million doses of Abdala.
–
:quality(80)/cdn-kiosk-api.telegraaf.nl/b7f6fd14-1ebf-11ec-87b5-02c309bc01c1.jpg?resize=150%2C150&ssl=1)